Mechanisms of chemotherapy resistance in triple-negative breast cancer—how we can rise to the challenge
M Nedeljković, A Damjanović - Cells, 2019 - mdpi.com
Triple-negative (TNBC) is the most lethal subtype of breast cancer owing to high
heterogeneity, aggressive nature, and lack of treatment options. Chemotherapy remains the …
heterogeneity, aggressive nature, and lack of treatment options. Chemotherapy remains the …
[HTML][HTML] Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Anthracyclines have been important and effective treatments against a number of cancers
since their discovery. However, their use in therapy has been complicated by severe side …
since their discovery. However, their use in therapy has been complicated by severe side …
The diverse and complex roles of NF-κB subunits in cancer
ND Perkins - Nature Reviews Cancer, 2012 - nature.com
It is only recently that the full importance of nuclear factor-κB (NF-κB) signalling to cancer
development has been understood. Although much attention has focused on the upstream …
development has been understood. Although much attention has focused on the upstream …
An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is the most complex, aggressive and fatal subtype of
breast cancer. Owing to the lack of targeted therapy and heterogenic nature of TNBC …
breast cancer. Owing to the lack of targeted therapy and heterogenic nature of TNBC …
[HTML][HTML] Molecular mechanisms of etoposide
A Montecucco, F Zanetta, G Biamonti - EXCLI journal, 2015 - ncbi.nlm.nih.gov
Etoposide derives from podophyllotoxin, a toxin found in the American Mayapple. It was first
synthesized in 1966 and approved for cancer therapy in 1983 by the US Food and Drug …
synthesized in 1966 and approved for cancer therapy in 1983 by the US Food and Drug …
Molecular mechanisms, biomarkers and emerging therapies for chemotherapy resistant TNBC
Triple-negative breast cancer (TNBC) is associated with high recurrence rates, high
incidence of distant metastases, and poor overall survival (OS). Taxane and anthracycline …
incidence of distant metastases, and poor overall survival (OS). Taxane and anthracycline …
Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review
M Mohajeri, A Sahebkar - Critical reviews in oncology/hematology, 2018 - Elsevier
Doxorubicin (DOX)-induced toxicity and resistance are major obstacles in chemotherapeutic
approaches. Despite effective in the treatment of numerous malignancies, some clinicians …
approaches. Despite effective in the treatment of numerous malignancies, some clinicians …
PD-1/PD-L1 and DNA damage response in cancer
M Kciuk, D Kołat, Ż Kałuzińska-Kołat, M Gawrysiak… - Cells, 2023 - mdpi.com
The application of immunotherapy for cancer treatment is rapidly becoming more
widespread. Immunotherapeutic agents are frequently combined with various types of …
widespread. Immunotherapeutic agents are frequently combined with various types of …
Evolution and roles of stanniocalcin
BHY Yeung, AYS Law, CKC Wong - Molecular and cellular endocrinology, 2012 - Elsevier
In fish, stanniocalcin-1 (STC1) is a key endocrine factor that acts on gill, intestine and kidney
to regulate serum calcium and phosphate homeostasis. The recent identification and study …
to regulate serum calcium and phosphate homeostasis. The recent identification and study …
Mechanisms of doxorubicin resistance in hepatocellular carcinoma
J Cox, S Weinman - Hepatic oncology, 2016 - Taylor & Francis
Hepatocellular carcinoma, one of the most common solid tumors worldwide, is poorly
responsive to available chemotherapeutic approaches. While systemic chemotherapy is of …
responsive to available chemotherapeutic approaches. While systemic chemotherapy is of …